Fact CheckerSign in

NCT05704764Active, not recruiting

Using the Ending Self-Stigma Intervention to Reduce Internalized Stigma Among People Living With HIV Who Use Substances

IRIS: Intervention to Reduce Internalized Stigma (IRIS) Among People Living With HIV Who Use Substances

Source: ClinicalTrials.gov · Last updated 20 Jul 2025

Brief summary (registry, in English)

The goal of this clinical trial is to test an intervention to reduce stigma among people living with HIV who use opioids and cocaine. The main question it aims to answer is: \- Does reducing internalized stigma about HIV and/or drug use lead to improved HIV care outcomes? After a year spent adapting an existing intervention to be applied specifically among people living with HIV who use substances, 70 participants will be randomized to receive either treatment-as-usual or the newly adapted intervention. The intervention itself will consist of five one-on-one sessions with a trained interventionist to discuss and work through the stigmas people commonly associate with HIV and/or substance use.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
70 (estimated)
First submitted
20 Jan 2023
Start date
17 Feb 2023
Primary completion date
31 Mar 2026
Lead sponsor
Friends Research Institute, Inc.
Diseases
HIV
NCT number
NCT05704764

What you commit to

  • Study type: Interventional
  • Planned participants: 70
  • From 17 Feb 2023 to the primary completion date, 31 Mar 2026
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Does not meet all inclusion criteria.

Who the study is looking for

  • 18+ years of age
  • English speaking
  • Living with HIV
  • Self-report recent drug and/or alcohol use OR currently enrolled in substance use treatment
  • Willing and able to provide full informed consent
  • Responds affirmatively to having ever experienced one or more of the following types of stigma related to HIV status or SU: (1) enacted, (2) anticipated, and/or internalized.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Maryland School of Medicine
Coordinator of this site? Confirm its status
BaltimoreUnited StatesUnknown status
Friends Research Institute, Inc. Satellite Office
Coordinator of this site? Confirm its status
NewhallUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.